A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease.

Yvelise FerroRoberta PujiaElisa MazzaLidia LascalaOscar LodariSamantha MaurottiArturo PujiaTiziana Montalcini

Published in: Journal of translational medicine (2022)

Our results showed that a new combination of bioactive molecules as nutraceutical was safe and effective in reducing liver fat content over 12 weeks in individuals with hepatic steatosis. Trial registration ISRCTN, ISRCTN70887063. Registered 03 August 2021-retrospectively registered, https://doi.org/10.1186/ISRCTN70887063.

Keyphrases

adipose tissue
study protocol
clinical trial
high fat diet
phase iii
phase ii
randomized controlled trial
fatty acid
gestational age
skeletal muscle